Misplaced Pages

Valiltramiprosate

Article snapshot taken from Wikipedia with creative commons attribution-sharealike license. Give it a read and then ask your questions in the chat. We can research this topic together.
Chemical compound

Pharmaceutical compound
Valiltramiprosate
Clinical data
Other namesALZ-801; BLU8499
Legal status
Legal status
  • Investigational
Identifiers
IUPAC name
  • 3-amino]propane-1-sulfonic acid
CAS Number
PubChem CID
DrugBank
ChemSpider
UNII
KEGG
ChEMBL
Chemical and physical data
FormulaC8H18N2O4S
Molar mass238.30 g·mol
3D model (JSmol)
SMILES
  • CC(C)(C(=O)NCCCS(=O)(=O)O)N
InChI
  • InChI=1S/C8H18N2O4S/c1-6(2)7(9)8(11)10-4-3-5-15(12,13)14/h6-7H,3-5,9H2,1-2H3,(H,10,11)(H,12,13,14)/t7-/m0/s1
  • Key:NRZRFNYKMSAZBI-ZETCQYMHSA-N

Valiltramiprosate is an investigational new drug that is being evaluated to treat early Alzheimer's disease. It is an amyloid precursor protein antagonist.

References

  1. "Valiltramiprosate - Alzheon". AdisInsight. Springer Nature Switzerland AG.
  2. Lee D, Antonsdottir IM, Clark ED, Porsteinsson AP (May 2024). "Review of valiltramiprosate (ALZ-801) for the treatment of Alzheimer's disease: a novel small molecule with disease modifying potential". Expert Opinion on Pharmacotherapy. 25 (7): 791–799. doi:10.1080/14656566.2024.2360069. PMID 38814590.
Stub icon

This pharmacology-related article is a stub. You can help Misplaced Pages by expanding it.

Categories: